Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)
Condition:   Multiple SclerosisIntervention:   Biological: Interferon beta-1b (Betaseron, BAY86-5046)Sponsor:   BayerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2012 Category: Research Source Type: clinical trials

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)
Condition:   Multiple SclerosisIntervention:   Biological: Interferon beta-1b (Betaseron, BAY86-5046)Sponsor:   BayerRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2012 Category: Research Source Type: clinical trials

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)
Condition:   Multiple SclerosisIntervention:   Biological: Interferon beta-1b (Betaseron, BAY86-5046)Sponsor:   BayerRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2012 Category: Research Source Type: clinical trials

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)
Condition:   Multiple SclerosisIntervention:   Biological: Interferon beta-1b (Betaseron, BAY86-5046)Sponsor:   BayerRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2012 Category: Research Source Type: clinical trials

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)
Condition:   Multiple SclerosisIntervention:   Biological: Interferon beta-1b (Betaseron, BAY86-5046)Sponsor:   BayerRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2012 Category: Research Source Type: clinical trials

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)
Condition:   Multiple SclerosisIntervention:   Biological: Interferon beta-1b (Betaseron, BAY86-5046)Sponsor:   BayerRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2012 Category: Research Source Type: clinical trials

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)
Condition:   Multiple SclerosisIntervention:   Biological: Interferon beta-1b (Betaseron, BAY86-5046)Sponsor:   BayerRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2012 Category: Research Source Type: clinical trials

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)
Condition:   Multiple SclerosisIntervention:   Biological: Interferon beta-1b (Betaseron, BAY86-5046)Sponsor:   BayerRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2012 Category: Research Source Type: clinical trials